A/P 12.5/15 (Alogliptin benzoate and pioglitazone hydrochloride 12.5 mg / 15 mg)
This pill with imprint "A/P 12.5/15" is Yellow, Round and has been identified as Alogliptin benzoate and pioglitazone hydrochloride 12.5 mg / 15 mg. It is supplied by Perrigo New York Inc..
Alogliptin/pioglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Alogliptin/pioglitazone 12.5 mg / 15 mg is not a controlled substance under the Controlled Substance Act (CSA).
Alogliptin benzoate and pioglitazone hydrochloride
- Imprint:
- A/P 12.5/15
- Strength:
- 12.5 mg / 15 mg
- Color:
- Yellow
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Perrigo New York Inc.
- National Drug Code (NDC):
- 45802-0238
More about alogliptin/pioglitazone
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: antidiabetic combinations
Consumer resources
Other brands: Oseni
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
